CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6605428.pdf
Reference31 articles.
1. Arisio R, Sapino A, Cassoni P, Accinelli G, Cuccorese MC, Mano MP, Bussolati G (2000) What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas? J Clin Pathol 53: 846–850
2. Bahadur N, Leathart JB, Mutch E, Steimel-Crespi D, Dunn SA, Gilissen R, Houdt JV, Hendrickx J, Mannens G, Bohets H, Williams FM, Armstrong M, Crespi CL, Daly AK (2002) CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol 64: 1579–1589
3. Belton O, Fitzgerald DJ (2003) Cyclooxygenase isoforms and atherosclerosis. Expert Rev Mol Med 5: 1–18
4. Boruban MC, Yasar U, Babaoglu MO, Sencan O, Bozkurt A (2006) Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients. J Chemother 18: 421–424
5. Chebil G, Bendahl PO, Ferno M (2003) Estrogen and progesterone receptor assay in paraffin-embedded breast cancer—reproducibility of assessment. Acta Oncol 42: 43–47
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transcription Factor HNF4A is Involved in Breast Cancer Recurrence;2024-03-25
2. Association of CYP1A2 Gene rs17861162 Polymorphism and Breast Cancer Risk in Iranian Women: A Case-Control Study;Gene, Cell and Tissue;2023-12-08
3. Clinical implications and immunological features of iron metabolism-related gene prognostic signature in breast cancer;2022-11-30
4. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect;Clinical Pharmacokinetics;2022-09-30
5. Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis;Expert Reviews in Molecular Medicine;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3